PR Newswire
BORDEAUX, France, February 25, 2016
BORDEAUX, France, February 25, 2016 /PRNewswire/ --
1 - 2015 results: growth in each of the group's three activities
Consolidated revenue rose 57% year-on-year to €14.1 million in 2015, gaining from positive trends in all three segments:
The two additional engines due to come on stream at the CHO Morcenx plant at the end of 2016 will bring the plant to its rated capacity, lead to deliver of Final Acceptance and alter the division's cash flow profile as a result.
At the same time, the plan to gradually roll out the other power plants is continuing, in accordance with the required administrative process. It will require specific funding suited to this type of project, which is currently being assessed and structured to protect the interests of and optimise value creation for Europlasma shareholders.
Trends remain very promising in early 2016 with order intakes clearly on the upside, indicating the growing interest on the part of both French and European industry for neutralising the hazards of asbestos waste once and for all.
2 - Cash position
The concurrent development of the 3 business units is still consuming cash for the time being, especially for CHO POWER until the 2 additional engines are put into operation, which will enable the CHO Morcenx plant to reach nominal capacity and economic performance.
At 31 December 2015, the group's cash amounted to €6.8 million. This includes financing of the engines spread over the financial year in accordance with the percentage of completion of the contract by the supplier.
To meet its cash requirements in 2016 to support its development, the group is implementing a funding plan that combines equity line financing with actions on working capital requirements.
3 - Equity line
The group has secured an equity line for a maximum amount of €10 million with Kepler Cheuvreux.
This equity line will enable the group to gain more leeway, diversify its sources of funding, and meet its cash requirements with flexibility.
The terms of the transaction, are given below, and an explanatory Q&A document on the equity line is available on http://www.europlasma.com.
Jean-Eric Petit, Chief Executive Officer of Europlasma, made the following statement: "The growth in revenue in all three business units reflects the company's recovery strategy over the past two years. Vigorous development and recovery efforts will continue but will require additional funding in 2016. The equity line has already proved its relevance in supporting the development of other industrial companies. Through its modularity, it will provide the Group with additional visibility and comfort. Access to sufficient financing for a growth stock like Europlasma and in a tough stock market environment proves the strength of our positioning and vision, and the relevance of our operational advances."
Terms of the transaction
This financing has a flexible structure based on two tranches: a first tranche of €5 million starting from the signature of the agreement, and a second tranche bringing the total amount to €10 million, that can be activated 6 months later.
Europlasma will control the pace of the financial support provided by Kepler Cheuvreux and may suspend or terminate the agreement at any time.
Within the framework of this system, and provided that the terms defined by the parties are respected, Kepler Cheuvreux has made a firm and final commitment to subscribe, over the next 6 months, for an amount equal to €5 million, i.e. an indicative number of shares of approximately 7,128,647[(1)], representing 10.2% of the Company's current share capital.
The issue price of new shares will correspond to the weighted average market price preceding the issue, reduced by a maximum discount of 8%. This discount will enable Kepler Cheuvreux, which does not aim to retain Europlasma's share capital, to act as a financial intermediary and to guarantee the subscription of shares as part of a firm commitment.
This transaction is implemented pursuant to the 10th resolution of the combined annual shareholders' meeting of 24 June 2015.
Should the 1st tranche[(2)] be used in full, a shareholder owning 1.00% of Europlasma's capital before its implementation would see their stake decrease to 0.91% of the capital on a non-diluted basis[(3)], and 0.95% of the capital on a diluted basis[(4)].
If necessary, the implementation of the 2nd tranche will be detailed in a press release.
The number of shares issued as part of this agreement and admitted to trading will be published in a Euronext market notice and communicated on the Europlasma website.
For more information regarding the Equity Line, a Q&A is online on the company's website at the following link http://www.europlasma.com/en/regulated-information/financial-press-releases.html.
Disclaimer
This release contains provisional information on the best estimates of the Management at the date of their publication. This information is by nature subject to risks and uncertainties which are difficult to predict and generally outside the Group's field of action. These risks include the risks listed in the Group's reference document available on its website http://www.europlasma.com.
Consequently, the future performance of the Group may differ significantly from the provisional data communicated and the Group can make no commitment to the achievement of these provisional elements.
About EUROPLASMA
At the heart of environmental issues, Europlasma designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint.
Europlasma is listed on Alternext (FR0000044810-ALEUP). For more information: http://www.europlasma.com
Contact
Europlasma
Anne BORDERES
Tel: +33(0)556-497-000
E-mail: contactbourse@europlasma.com
Kepler Cheuvreux
Thierry du Boislouveau
Tel.: +33(0)1-53-65-36-85
thierry.du-boislouveau@keplercf.com
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.